Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In essential hypertension, a change in the renal resistive index is associated with a change in the ratio of 24-hour diastolic to systolic blood pressure.

Physiological research·2022
Same author

Association between 24-hour diastolic blood pressure and renal function in patients receiving treatment for essential hypertension.

The Journal of international medical research·2019
Same author

A complex four-point method for the evaluation of ohmic and faradaic losses within a redox flow battery single-cell.

MethodsX·2019
Same author

[Avulsion of the Proximal Hamstring Insertion. Case Reports].

Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca·2016
Same author

ECG body surface mapping in patients with gestational diabetes mellitus and optimal metabolic compensation.

Physiological research·2015
Same author

Flow-mediated vasodilatation in the patients with anorexia nervosa.

Bratislavske lekarske listy·2013

Related Experiment Video

Updated: Jun 27, 2026

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
03:57

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy

Published on: July 14, 2023

[Hypoglycaemic periodic paralysis in hyperthyroidism patients].

J Kratochvíl1, J Masopust, V Martínková

  • 1Jednotka intenzivní metabolické péce Interní kliniky 2. Iékarské fakulty UK a FN Motol Praha. jaroslavkratochvil@hotmail.com

Vnitrni Lekarstvi
|December 17, 2008
PubMed
Summary
This summary is machine-generated.

Hypokalemic periodic paralysis (HPP) is a rare condition causing sudden muscle weakness due to potassium shifts. This review focuses on HPP in hyperthyroid patients, discussing its causes, symptoms, and management.

Related Experiment Videos

Last Updated: Jun 27, 2026

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
03:57

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy

Published on: July 14, 2023

Area of Science:

  • Endocrinology
  • Neurology
  • Genetics

Background:

  • Hypokalemic periodic paralysis (HPP) is a rare neuromuscular disorder characterized by acute muscle weakness or paralysis.
  • It results from a massive shift of potassium into cells, often triggered by elevated insulin or catecholamines.
  • HPP can be familial, linked to inherited ion channel defects, or acquired, particularly in hyperthyroid individuals.

Observation:

  • This review examines two clinical cases of HPP in patients with hyperthyroidism.
  • It highlights the association between hyperthyroidism and the acquired form of HPP.
  • The study details clinical presentations and laboratory findings specific to this patient group.

Findings:

  • Hyperthyroidism is a significant risk factor for acquired hypokalemic periodic paralysis.
  • Key triggers include elevated insulin and catecholamine levels, leading to hypokalemia.
  • Associated conditions like hypophosphatemia and hypomagnesemia may be present, though acid-base balance is typically normal.

Implications:

  • Early diagnosis and management of hyperthyroidism are crucial for preventing HPP attacks in susceptible individuals.
  • Understanding the pathogenesis aids in developing targeted prevention and treatment strategies.
  • This review emphasizes the importance of considering HPP in hyperthyroid patients presenting with muscle weakness.